EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Primary Tumor‐Associated Loss of the Y Chromosome and Clinical Outcome in Metastatic Colorectal Cancer

Anaëlle Isnard, Marie Decraecker, Benjamin Fernandez, Denis Smith, Pierre Dubus, Sandrine Dabernat, Olivier Mansier iD, Samuel Amintas iD

Genes, Chromosomes and Cancer · 2026-06 · 65 (6)

DOI: 10.1002/gcc.70147 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, Chromosomes and Cancer, online erschienen am 14.06.2026. Verfasst von Anaëlle Isnard und 7 weiteren Autor:innen. Beteiligte Einrichtung: CHU Bordeaux, Tumor Biology and Tumor Bank Laboratory, Pessac, France. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Chromosomes, Human, Y. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Alterations of the Y chromosome are frequent events in solid tumors, yet their biological and clinical significance remains incompletely understood. In colorectal cancer (CRC), recent studies have suggested context‐dependent roles of Y‐linked genes in tumor progression, while the impact of tumor‐associated loss of the Y chromosome (LoY) in metastatic disease has not been clearly established.

Methods

We retrospectively analyzed primary tumor samples from 91 male patients with metastatic CRC treated at a single institution. Tumor LoY status was assessed using a droplet digital PCR–based assay. Associations between LoY, clinicopathological characteristics, KRAS/BRAF mutation status, and patient outcomes, including progression‐free survival (PFS) and overall survival (OS), were evaluated. Exploratory analyses of TCGA‐COAD/READ data were performed using chromosome Y copy‐number segment data, mutation data, and survival information.

Results

Tumor LoY was detected in 46 cases (50.5%) and was more frequent in rectal cancers ( p = 0.038). LoY was not associated with age, microsatellite instability status, KRAS or BRAF mutations. While PFS did not differ according to LoY status, OS was longer in patients with LoY‐positive tumors ( p = 0.046). In multivariable analysis, LoY showed a non‐significant trend toward improved OS (HR = 0.52, 95% CI: 0.25–1.10; p = 0.07). In exploratory TCGA analyses, chromosome Y copy‐number signal did not significantly differ between colon and rectal cancers, but lower chromosome Y signal was associated with worse OS, particularly in TCGA‐COAD after adjustment for age and KRAS / BRAF status.

Conclusions

LoY is a frequent chromosomal alteration in metastatic CRC and appears enriched in rectal primary tumors in our cohort. Its association with clinical outcome may depend on disease stage, molecular background, and analytical methodology. These findings support further investigation of Y chromosome loss as a context‐dependent biomarker in CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsChromosomes, Human, YHumansMaleProto-Oncogene Proteins B-rafMiddle AgedProto-Oncogene Proteins p21(ras)AgedMutationRetrospective StudiesNeoplasm MetastasisAdultAged, 80 and overPrognosis

Stichwörter der Autor:innen

KRASbiomarkerchromosomal instabilitycolorectal cancerloss of Y chromosomesurvival

Substanzen

Proto-Oncogene Proteins B-rafProto-Oncogene Proteins p21(ras)BRAF protein, humanKRAS protein, human

Autor:innen und Institutionen

  • CHU Bordeaux, Tumor Biology and Tumor Bank Laboratory, Pessac, France.
  • BRIC (BoRdeaux Institute of Oncology), INSERM, University of Bordeaux, Bordeaux, France.
  • Oncology Unit, Haut Lévêque Hospital, University Hospital Center of Bordeaux, Pessac, France.
  • CHU Bordeaux, Colorectal Digestive Surgery Department, Bordeaux, France.
  • CHU Bordeaux, Biochemistry Laboratory, Bordeaux, France.
  • CHU Bordeaux, Hematology Laboratory, Bordeaux, France.

ORCID-Profile: Olivier Mansier, Samuel Amintas

Zitieren

APA

Isnard, A., Decraecker, M., Fernandez, B., Smith, D., Dubus, P., Dabernat, S., Mansier, O., & Amintas, S. (2026). Primary Tumor‐Associated Loss of the Y Chromosome and Clinical Outcome in Metastatic Colorectal Cancer. Genes, Chromosomes and Cancer, 65(6). https://doi.org/10.1002/gcc.70147

Vancouver

Isnard A, Decraecker M, Fernandez B, Smith D, Dubus P, Dabernat S, et al. Primary Tumor‐Associated Loss of the Y Chromosome and Clinical Outcome in Metastatic Colorectal Cancer. Genes, Chromosomes and Cancer. 2026;65(6). doi:10.1002/gcc.70147

BibTeX
@article{Isnard2026,
  author = {Isnard, Anaëlle and Decraecker, Marie and Fernandez, Benjamin and Smith, Denis and Dubus, Pierre and Dabernat, Sandrine and Mansier, Olivier and Amintas, Samuel},
  title = {Primary Tumor‐Associated Loss of the Y Chromosome and Clinical Outcome in Metastatic Colorectal Cancer},
  journal = {Genes, Chromosomes and Cancer},
  year = {2026},
  volume = {65},
  number = {6},
  doi = {10.1002/gcc.70147}
}
Kostenlos starten →